Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair'
NQ Score
53/100
N1 Content Completeness
10
Key facts
- Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair'
- Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
- Source: PR TIMES
- Date: Tue Jun 02 2026 22:00:01 GMT+0900 (Japan Standard Time)
Direct answer
Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
- Citation
- Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair' (Tue Jun 02 2026 22:00:01 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Tue Jun 02 2026 22:00:01 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
AI Analysis
Frequently Asked Questions
- Q: Do Taiwanese consumers value patents in health products?
- A: Yes, products backed by scientific evidence and clinical trial data are highly regarded in the Taiwanese market.
- Q: What are the key facts in this article?
- A: Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
- Q: What is the direct answer?
- A: Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.